Ketamine’s antidepressant effects are supported by well-established neuroscience. It works primarily by blocking NMDA receptors, which changes how the brain processes glutamate—a key neurotransmitter involved in learning, memory, and mood regulation.
Clinical Research & How Ketamine Therapy Works
Science And Research
Ketamine Research Studies
A randomized controlled trial of patients with chronic PTSD found that repeated ketamine infusions led to rapid and significant reductions in PTSD symptoms, often within 24 hours of treatment. Compared to the control group, patients receiving ketamine experienced greater and more sustained improvement over the two-week study period, supporting its role as a promising treatment for PTSD. Source: Feder et al., 2023, American Journal of Psychiatry
A meta-analysis of randomized controlled trials found that ketamine therapy consistently improves both PTSD and depression symptoms, with many patients experiencing relief within just one day. The findings highlight ketamine’s effectiveness as a fast-acting treatment option, particularly for individuals who have not responded to traditional antidepressants. Source: Annals of Pharmacotherapy, 2023
Multiple randomized clinical trials show that ketamine produces significantly higher response and remission rates in treatment-resistant depression compared to placebo. Many patients reported improvement within 24–48 hours, with some achieving full remission after repeated treatments, making ketamine one of the most rapidly acting antidepressant options available today. Source: National Center for Biotechnology Information
A systematic review and meta-analysis of clinical trials concluded that ketamine provides a statistically significant improvement in PTSD symptoms compared to placebo. While results vary between individuals, the overall evidence supports ketamine therapy as a clinically meaningful option for PTSD, especially in patients who have not found relief with standard treatments.Source: PubMed Central
Your content goes here
How Ketamine Works in the Brain
Promoting Neuroplasticity & Rebuilding Neural Connections
Chronic stress and depression can weaken the brain’s communication networks, often leaving individuals stuck in repetitive, negative thought patterns. By enhancing glutamate signaling, ketamine helps promote neuroplasticity—the brain’s ability to form new connections and adapt over time. It may also stimulate the growth of new synapses, supporting more flexible, resilient thinking. In practical terms, this can help individuals reframe experiences, better manage stress and triggers, and shift long-standing perspectives.
Supporting Brain Repair Through BDNF
A key downstream effect of ketamine is the increase of BDNF (brain-derived neurotrophic factor), a protein essential for the growth, repair, and maintenance of brain cells. Lower levels of BDNF have been associated with depression and chronic stress, both of which can impair connectivity in areas of the brain responsible for mood and decision-making.
Emotional & Cognitive Shifts for Lasting Change
These neurological changes help explain why many individuals report more than temporary symptom relief—they often experience a meaningful shift in perspective that extends beyond treatment. Ketamine may create a window of emotional openness and mental clarity, allowing people to revisit difficult thoughts or memories with greater calm and distance. In psychology, this is often described as an expanded “window of tolerance,” which can support deeper emotional processing and long-term change rather than simply masking symptoms or creating emotional numbness.
“Ketamine appears to produce rapid relief of depressive symptoms, often within hours, making it one of the most promising developments in modern psychiatry.”
— Harvard Health Publishing Physicians
“What makes ketamine unique is its ability to promote the regrowth of synaptic connections in the brain.”
— Dr. John Krystal, Yale School of Medicine
“Ketamine has demonstrated a rapid and robust antidepressant effect in patients who have not responded to traditional treatments.”
— Physician-authored clinical research (peer-reviewed)
“For some individuals, ketamine can reduce severe symptoms of depression and suicidality in a way that other treatments have not.”
— Harvard-affiliated researchers
Frequently asked questions
When prescribed and monitored by a licensed physician, ketamine has a strong safety profile and has been used in medicine for decades.
Many patients report noticeable improvements within hours to days, compared to weeks with traditional medications.
Yes—ketamine therapy is legal in the United States when prescribed and administered by a licensed medical provider. Ketamine itself is an FDA-approved medication (originally approved as an anesthetic), and doctors are legally allowed to prescribe it “off-label” for conditions like depression, anxiety, and PTSD.
The experience of ketamine therapy is typically calming, introspective, and uplifting. Many clients describe a sense of lightness or floating, along with a peaceful, dreamlike state. Sessions generally last between 45 minutes and one hour, and most people are able to return to their normal daily activities soon after.
Typically, it’s considered for those with treatment-resistant depression or conditions that haven’t improved with standard medications, after proper medical evaluation.
Most ketamine side effects are temporary, manageable, and occur during or shortly after treatment. Serious complications are rare when therapy is conducted responsibly and with proper medical oversight.
We do not accept insurance but we do offer free consultations.
Ketamine does not have the same addictive profile as substances like opioids or benzodiazepines because it does not strongly activate the brain’s reward and craving pathways in the same way. Most addictive drugs work by flooding the brain with dopamine, creating a cycle of craving → reward → dependence. Ketamine works differently.
Instead, ketamine primarily affects the NMDA receptor and glutamate system, which is involved in learning, memory, and neuroplasticity—not the classic reward circuitry. This is why patients typically don’t experience the same pattern of compulsive use or withdrawal seen with highly addictive substances.
